Affordability Check
How to afford IXEMPRA
Generic name: ixabepilone
Pick how you're covered. We'll show you the cheapest legitimate way to get IXEMPRA — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About IXEMPRA and its cost
What is this medication? Ixempra is a prescription chemotherapy medication used primarily to treat adults with advanced stages of breast cancer. It is specifically indicated for patients whose cancer has either spread to other parts of the body, known as metastatic breast cancer, or is locally advanced and no longer responds to other standard treatments like taxanes or anthracyclines. This drug belongs to a class of medications called epothilone analogs, which work by stopping the growth and spread of cancer cells by interfering with their ability to divide. The medication is often administered in combination with another drug called capecitabine for patients who have already tried certain chemotherapy regimens without success. In some cases, it may be used as a standalone treatment for individuals whose cancer has proven resistant to various other types of chemotherapy, including taxanes and anthracyclines. Ixempra is given through an intravenous infusion in a clinical setting by a healthcare professional, and its use is typically determined after evaluating a patient's specific treatment history and current medical needs.
IXEMPRA is made by R-Pharm US. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford IXEMPRA?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for IXEMPRA?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But R-Pharm US has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover IXEMPRA?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about IXEMPRA
Full IXEMPRA drug page
FDA label, prior authorization rules, full indications list
More options for Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3